The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

Maria Zachou Pagona Flevari Narjes Nasiri-Ansari Constantinos Varytimiadis Evangelos Kalaitzakis Evanthia Kassi Theodoros Androutsakos

Published in: European journal of clinical pharmacology (2023)

In patients with NAFLD and diabetes, pioglitazone, GLP1 RAs, and SGLT2i seem to be logical treatment options. Larger studies are needed before these drugs can be recommended for non-diabetic individuals.

Keyphrases

type diabetes
wound healing
cardiovascular disease
metabolic syndrome
adipose tissue
insulin resistance
weight loss